Arlington Heights, IL, Aug. 16, 2017 -- The American Society of Plastic Surgeons (ASPS) is proud to recognize Allergan as a Platinum Level sponsor of Plastic Surgery The Meeting. Bringing together the best and brightest surgeons in the specialty, Plastic Surgery The Meeting is a platform for the world’s largest gathering of plastic and reconstructive surgeons to share their expertise with colleagues from nearly 50 nations. It is the leading educational and networking event of the year for both plastic surgeons in the United States and around the globe.
|
|||
"Allergan is a valued partner in developing and manufacturing pharmaceuticals, medical devices, and biologic and tissue products for patients around the world,” said Debra Johnson, MD, president of the American Society of Plastic Surgeons. “We share a commitment to improving the quality of surgical outcomes and safety through physician and patient education and technological innovation.”
The ASPS Premier Support program provides industry partners with increased visibility and greater recognition for their support at Plastic Surgery The Meeting. Partnering with ASPS provides unprecedented opportunities to communicate and engage with aesthetic and reconstructive plastic surgeons from around the world.
“Our commitment to plastic surgery has never been greater as evidenced by our recent acquisitions of LifeCell, Zeltiq and Keller Medical. Allergan now offers one of the broadest portfolios of best-in-class technologies for plastic surgery and regenerative medicine,” said David Moatazedi, Senior Vice President, Allergan Medical. “Sponsoring Plastic Surgery The Meeting, which is known for its emphasis on education and improving patient outcomes, further demonstrates our commitment to excellence in plastic surgery.”
For more information, visit our Plastic Surgery The Meeting website.
About Allergan
Allergan plc, headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f1c867f0-26a2-4a2c-bebf-7e643dca12ad
Adam Ross American Society of Plastic Surgeons 773-332-4719 [email protected]


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 



